These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 1928034)
1. A comparative study of contrast agents for endoscopic retrograde pancreatography. Barkin JS; Casal GL; Reiner DK; Goldberg RI; Phillips RS; Kaplan S Am J Gastroenterol; 1991 Oct; 86(10):1437-41. PubMed ID: 1928034 [TBL] [Abstract][Full Text] [Related]
2. A randomised, prospective study comparing two contrast media in ERCP. Cunliffe WJ; Cobden I; Lavelle MI; Lendrum R; Tait NP; Venables CW Endoscopy; 1987 Sep; 19(5):201-2. PubMed ID: 3678161 [TBL] [Abstract][Full Text] [Related]
3. Iopamidol as contrast medium in endoscopic retrograde pancreatography: a prospective randomised comparison with diatrizoate. O'Connor HJ; Ellis WR; Manning AP; Lintott DJ; McMahon MJ; Axon AT Endoscopy; 1988 Sep; 20(5):244-7. PubMed ID: 3168937 [TBL] [Abstract][Full Text] [Related]
4. Trial of low versus high osmolar contrast media in endoscopic retrograde cholangiopancreatography. Banerjee AK; Grainger SL; Thompson RP Br J Clin Pract; 1990 Nov; 44(11):445-7. PubMed ID: 2282293 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the effect of non-ionic and ionic contrast agents on pancreatic histology in a canine model. Pfau PR; Mosley RG; Said A; Gopal DV; Fischer MC; Oberley T; Weiss J; Lee FT; Eckoff D; Reichelderfer M JOP; 2006 Jan; 7(1):27-33. PubMed ID: 16407615 [TBL] [Abstract][Full Text] [Related]
6. Iohexol and ioxaglate in peripheral angiography. Stiris MG; Laerum F Acta Radiol; 1987; 28(6):767-70. PubMed ID: 2962617 [TBL] [Abstract][Full Text] [Related]
7. Role of diclofenac in reducing post-endoscopic retrograde cholangiopancreatography pancreatitis. Khoshbaten M; Khorram H; Madad L; Ehsani Ardakani MJ; Farzin H; Zali MR J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e11-6. PubMed ID: 17683501 [TBL] [Abstract][Full Text] [Related]
8. The immediate effects of retrograde pancreatography on the pancreas. Kivisaari L; Alitalo I Eur J Radiol; 1984 Feb; 4(1):58-60. PubMed ID: 6723675 [TBL] [Abstract][Full Text] [Related]
9. Etanercept, a TNF-alpha binding agent, is ineffective in the prevention of post-ERCP pancreatitis in canines. Buscaglia JM; Simons BW; Prosser BJ; Ruben DS; Giday SA; Magno P; Clarke JO; Shin EJ; Kalloo AN; Kantsevoy SV; Gabrielson KL; Jagannath SB JOP; 2008 Jul; 9(4):456-67. PubMed ID: 18648137 [TBL] [Abstract][Full Text] [Related]
10. Use of octreotide-acetate in preventing pancreatitis-like changes following therapeutic endoscopic retrograde cholangiopancreatography. Duvnjak M; Supanc V; Simicević VN; Hrabar D; Troskot B; Smircić-Duvnjak L; Bekavac-Beslin M Acta Med Croatica; 1999; 53(3):115-8. PubMed ID: 10705631 [TBL] [Abstract][Full Text] [Related]
11. The prophylactic effect of somatostatin on post-therapeutic endoscopic retrograde cholangiopancreatography pancreatitis: a randomized, multicenter controlled trial. Lee KT; Lee DH; Yoo BM Pancreas; 2008 Nov; 37(4):445-8. PubMed ID: 18953260 [TBL] [Abstract][Full Text] [Related]
12. Nafamostat mesylate in the prevention of post-ERCP pancreatitis and risk factors for post-ERCP pancreatitis. Choi CW; Kang DH; Kim GH; Eum JS; Lee SM; Song GA; Kim DU; Kim ID; Cho M Gastrointest Endosc; 2009 Apr; 69(4):e11-8. PubMed ID: 19327467 [TBL] [Abstract][Full Text] [Related]
14. A prospective randomized trial of cannulation technique in ERCP: effects on technical success and post-ERCP pancreatitis. Bailey AA; Bourke MJ; Williams SJ; Walsh PR; Murray MA; Lee EY; Kwan V; Lynch PM Endoscopy; 2008 Apr; 40(4):296-301. PubMed ID: 18389448 [TBL] [Abstract][Full Text] [Related]
15. Can a single dose corticosteroid reduce the incidence of post-ERCP pancreatitis? A randomized, prospective control study. Kwanngern K; Tiyapattanaputi P; Wanitpukdeedecha M; Navicharern P J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S42-5. PubMed ID: 16623000 [TBL] [Abstract][Full Text] [Related]
16. Indomethacin may reduce the incidence and severity of acute pancreatitis after ERCP. Sotoudehmanesh R; Khatibian M; Kolahdoozan S; Ainechi S; Malboosbaf R; Nouraie M Am J Gastroenterol; 2007 May; 102(5):978-83. PubMed ID: 17355281 [TBL] [Abstract][Full Text] [Related]
18. Experimental pancreatography: a comparison of three contrast media. Saari A; Kivisaari L; Standertskjöld-Nordenstam CG; Brackett K; Schröder T Scand J Gastroenterol; 1988 Jan; 23(1):53-8. PubMed ID: 3344398 [TBL] [Abstract][Full Text] [Related]
19. Different contrast agents and development of pancreatitis after endoscopic retrograde pancreatography. Short TP; Thomas E Am J Gastroenterol; 1992 May; 87(5):682-3; author reply 684-5. PubMed ID: 1595669 [No Abstract] [Full Text] [Related]